Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
Top Cited Papers
- 16 May 2012
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 92 (1), 87-95
- https://doi.org/10.1038/clpt.2011.371
Abstract
The promise of “personalized medicine” guided by an understanding of each individual's genome has been fostered by increasingly powerful and economical methods to acquire clinically relevant information. We describe the operational implementation of prospective genotyping linked to an advanced clinical decision‐support system to guide individualized health care in a large academic health center. This approach to personalized medicine entails engagement between patient and health‐care provider, identification of relevant genetic variations for implementation, assay reliability, point‐of‐care decision support, and necessary institutional investments. In one year, approximately 3,000 patients, most of whom were scheduled for cardiac catheterization, were genotyped on a multiplexed platform that included genotyping for CYP2C19 variants that modulate response to the widely used antiplatelet drug clopidogrel. These data are deposited into the electronic medical record (EMR), and point‐of‐care decision support is deployed when clopidogrel is prescribed for those with variant genotypes. The establishment of programs such as this is a first step toward implementing and evaluating strategies for personalized medicine. Clinical Pharmacology & Therapeutics (2012); 92 1, 87–95. doi:10.1038/clpt.2011.371Keywords
This publication has 44 references indexed in Scilit:
- Medium- to High-Throughput SNP Genotyping Using VeraCode MicrobeadsPublished by Springer Science and Business Media LLC ,2009
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug UsePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized MedicineClinical Pharmacology & Therapeutics, 2008
- ‘I’m Happy if I Can Help’Public Health Genomics, 2008
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesThe New England Journal of Medicine, 2007
- Patients’ and healthcare professionals’ views on pharmacogenetic testing and its future delivery in the NHSPharmacogenomics, 2007
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006
- Patients’ and physicians’ perspectives on pharmacogenetic testingPharmacogenomics, 2006
- A lay prescription for tailor-made drugs—focus group reflections on pharmacogenomicsHealth Policy, 2005
- Effects Of Current And Future Information Technologies On The Health Care WorkforceHealth Affairs, 2002